Operating

Non-cash litigation reserve adjustments

AbbVie Non-cash litigation reserve adjustments increased by 147.0% to $150.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 120.6%, from -$729.00M to $150.00M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ1 2026May 8, 2026

How to read this metric

Frequent large adjustments may signal ongoing legal instability or uncertainty regarding potential liabilities.

Detailed definition

This metric captures the net impact of non-cash adjustments to legal reserves, accounting for both the creation of new r...

Peer comparison

Used by large-cap companies in litigious industries to manage and report legal exposure.

Metric ID: abbv_litigation_reserve_adjustments

Historical Data

12 periods
 Q4 '21Q3 '22Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$142.00M$71.00M-$87.00M-$238.00M-$12.00M$39.00M$314.00M$167.00M-$729.00M-$21.00M-$319.00M$150.00M
QoQ Change-50.0%-222.5%-173.6%+95.0%+425.0%+705.1%-46.8%-536.5%+97.1%<-999%+147.0%
YoY Change-222.5%+460.9%+170.2%<-999%-153.8%-201.6%+120.6%
Range-$729.00M$314.00M
CAGR+2.0%
Avg YoY Growth-828.8%
Median YoY Growth-153.8%

Frequently Asked Questions

What is AbbVie's non-cash litigation reserve adjustments?
AbbVie (ABBV) reported non-cash litigation reserve adjustments of $150.00M in Q1 2026.
How has AbbVie's non-cash litigation reserve adjustments changed year-over-year?
AbbVie's non-cash litigation reserve adjustments increased by 120.6% year-over-year, from -$729.00M to $150.00M.
What does non-cash litigation reserve adjustments mean?
The net non-cash impact of changes in legal reserve estimates on the company's financial results.